Navigation Links
Third Clinical Study Confirms Treatment Guided By GeneSight Psychiatric Pharmacogenomics Test
Date:12/5/2013

sive symptoms over the 10 week trial period.  In contrast, the GeneSight group showed improved outcomes overall compared to current standard of care and greatest improvement in the 30% of patients previously taking genetically discordant medications. Based on objective genomic data, physicians for 100% of patients in the GeneSight-guided group used the report to either switch participants off medications discordant with their genetics to medications in the green bin or to adjust medication dosages versus only 50% of the physicians providing the typical standard of care.

"To my knowledge, this is the first real-world, double blind randomized control trial for pharmacogenomic intervention in psychiatry, making it an invaluable addition to the psychiatric literature," said Joel G. Winner, M.D., Medical Director at Assurex Health.  "The data in this paper align with our previous two published trials which show a doubling of response rate for major depressive disorder when the clinician uses GeneSight compared to those who did not use this integrated pharmacogenomic information."

"The Pine Rest RCT replicated and reaffirmed the clinical validity of GeneSight by prospectively categorizing and predicting which patients receiving current standard of care would have high, medium or low response to treatment using our patented combinatorial pharmacogenomic GeneSight test and actionable green, yellow and red medication stratification report," according to Bryan M. Dechairo, Ph.D., Senior Vice President, Medical Affairs & Clinical Development at Assurex Health.

These findings replicate results observed in two previous prospective joint clinical studies from Assurex Health and Mayo Clinic: the La Crosse Study published in Pharmacogenetics and Genomics (July 24, 2013) and the Hamm Study published in Translational Psychiatry (October
'/>"/>

SOURCE Assurex Health
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
2. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
3. Pro-Dex, Inc. Announces Fiscal 2012 Third Quarter Financial Results Conference Call and Webcast
4. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
5. Cardica Announces Fiscal 2012 Third Quarter Financial Results
6. Hill-Rom Announces Third Quarter 2012 Dividend
7. Cardinal Health Reports Third-Quarter Results
8. TPI to Host Third Quarter of Fiscal Year 2012 Earnings Conference Call on Tuesday, May 15, 2012 at 9:00 a.m. ET
9. Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results
10. ThermoGenesis Corp. To Announce Third Quarter Fiscal 2012 Results On May 10, 2012
11. Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... -- Finesse expands office in Leicester, United Kingdom ... of its operations in Leicester , ... for customers is expected shortly afterward. With ... the current office, the new premises will double the ... Finesse to bring on more service personnel. The new ...
(Date:2/26/2015)... , Feb. 26, 2015  AbbVie (NYSE: ... of studies in its neuroscience and oncology development ... 67 th American Academy of Neurology annual ... from April 18-25. The accepted abstracts feature results ... addition to investigational treatments in AbbVie,s pipeline. Presentations ...
(Date:2/26/2015)... , Feb. 26, 2015  Mobility Ventures LLC, an ... with Bank of America (NYSE: BAC ) ... receive financing of the revolutionary MV-1 - - the ... the ground up to provide safe and comfortable transportation ... use their loan to purchase a new MV-1 vehicle ...
Breaking Medicine Technology:New Finesse Office in United Kingdom 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3
... Actavis has received approval from the U.S. Food ... treatment of attention deficit/hyperactivity disorder (ADHD). Actavis ... 25 mg, 40 mg, 60 mg, 80 mg and 100 ... to Eli Lilly and Company,s Strattera®, has been set. The ...
... Services of America, Inc. (ROSA), a subsidiary of Ambulatory ... has entered into an agreement with the Department of ... School of Medicine to embark on a Cooperative Quality ... of Radiation Oncology will review quality assurance activities in ...
Cached Medicine Technology:Actavis Receives FDA Approval of Atomoxetine HCl Capsules 2Radiation Oncology Services of America, Inc. to Work With Washington University on Quality Assurance Initiative 2
(Date:3/1/2015)... CrossFit Attollo is a CrossFit gym located in Vancouver ... to new members. Now through the end of March ... will receive their fourth month half off. , ... The three month contract is only $264, dropping the price ... comes in at only $55. The special saves new members ...
(Date:2/28/2015)... February 28, 2015 In recent years Medical ... of practicing physicians as a way for them to expand ... regarding Cannabis as medicine. Since the FDA still lists Cannabis ... resources available to licensed physicians that can help guide ... Dr. Deborah Malka in Santa Cruz, CA is a ...
(Date:2/28/2015)... OR (PRWEB) February 28, 2015 In ... Duncan Fletcher of Game Change Athlete ... Shannon Leinert about the benefits of athlete development and ... some of the unique challenges that athletes face and ... and future success. , Fletcher became involved in athlete ...
(Date:2/28/2015)... 2015 With their commitment to achieving ... an additional exercise to their already robust library of ... most commonly known as, is often performed on a ... executed in a relatively safe manner and can be ... The full description of “Rope Pulls” is located in ...
(Date:2/28/2015)... Portland, Oregon (PRWEB) February 28, 2015 ... Portland, Oregon, is offering a new special. Throughout ... denture relines. , This service ... from sleep problems and pain. Patients may notice certain ... and need relining. These symptoms include: , 1.    Pain, ...
Breaking Medicine News(10 mins):Health News:CrossFit Gym in Vancouver WA Offers Spring Special 2Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2
... common vision problems can find glasses or contact lenses fairly ... affect the focus of light have more limited options and ... , At the University of Houston,s College of Optometry, ... latter population,s long-underserved needs by developing custom contact lenses. , ...
... The Certification Commission for Healthcare Information Technology (CCHIT®) today announced ... is a CCHIT Certified® 08 Ambulatory EHR, and meets the ... Ambulatory EHRs are designed for physician offices and clinics where ... ...
... May 13 President Barack Obama and Speaker ... meeting on health care reform this morning at the ... Joe Biden, House Majority Leader Steny Hoyer, and Chairmen ... are the Speaker,s remarks; the White House will provide ...
... - Exclusive videos by HealthiNation to feature Best Hospitals in ... May 13 U.S. News and ... today announced an exclusive web video series featuring a selection ... a ranking in U.S. News ,s prestigious 2009 ...
... In recognition of National Cystic Fibrosis Awareness ... to ring the closing bell of the New ... the leading organization in the United States devoted ... genetic disease.C. Richard Mattingly, executive vice president and ...
... levelsWASHINGTON, May 13 Eight million Americans are covered ... of more than 31 percent since last year, a ... (AHIP) finds. Health Savings Accounts were authorized starting ... a periodic census of its members participating in the ...
Cached Medicine News:Health News:UH optometrists make custom contact lenses for long-underserved patients 2Health News:UH optometrists make custom contact lenses for long-underserved patients 3Health News:UH optometrists make custom contact lenses for long-underserved patients 4Health News:Glenwood System LLC'S GlaceEMR Receives 08 CCHIT Certification,Software Complies with Updated Interoperability Requirements 2Health News:Glenwood System LLC'S GlaceEMR Receives 08 CCHIT Certification,Software Complies with Updated Interoperability Requirements 3Health News:Glenwood System LLC'S GlaceEMR Receives 08 CCHIT Certification,Software Complies with Updated Interoperability Requirements 4Health News:Pelosi: Health Care Legislation Will Be on the House Floor by the End of July 2Health News:U.S. News Media Group Announces 'America's Best Hospitals' Video Series 2Health News:U.S. News Media Group Announces 'America's Best Hospitals' Video Series 3Health News:U.S. News Media Group Announces 'America's Best Hospitals' Video Series 4Health News:Cystic Fibrosis Foundation Rings Bell to Close New York Stock Exchange 2Health News:Health Savings Account Enrollment Reaches Eight Million 2
Inquire...
... Pipette Tracker is an automated solution for ... and performance testing for all pipettes and ... from any balance Supports all ... 8655, DIN 12650, ISO 9000, NCCLS and ...
... V-shaped bottom allows easy withdrawal of solution ... bag ,• Corner pouring lips facilitate ... designed for 4, 8, and 12 channel ... withdrawal of practically all of the solution. ...
... V-shaped bottom allows easy withdrawal of solution ... bag, ,• Corner pouring lips facilitate ... designed for 4, 8, and 12 channel ... permits withdrawal of practically all of the ...
Medicine Products: